netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

Breakthrough Gene Therapy Prevents Retinal Degeneration

Damaged, untreated retina

Image shows damage (pink) to the retina. (Image courtesy of Rajendra Kumar-Singh, Tufts University School of Medicine)

Research to Prevent Blindness-supported researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts have demonstrated that non-viral gene therapy, delivered by nanoparticles, can delay the onset of some forms of eye disease and preserve vision. The study brings researchers closer to a non-viral gene therapy treatment for degenerative eye disorders.

"The most common approach to gene therapy involves using a virus to deliver DNA to cells. While viruses are very efficient carriers, they can prompt immune responses that may lead to inflammation, cancer, or even death. Non-viral methods offer a safer alternative, but until now, efficiency has been a significant barrier," said senior author Rajendra Kumar-Singh, PhD, associate professor of ophthalmology at Tufts University School of Medicine (TUSM).

Read the full article.

Read the online abstract.

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.